Staar Surgical (STAA) Net Income towards Common Stockholders (2010 - 2026)

Staar Surgical has reported Net Income towards Common Stockholders for 17 years, with the latest figure at $5.2 million in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 109.6% year-over-year to $5.2 million; the trailing twelve-month figure through Apr 2026 stood at $39.8 million (up 134.63% YoY), and the FY2026 full-year result was -$19.6 million, up 69.34% from the prior year.
• Net Income towards Common Stockholders for Q2 2026 stood at $5.2 million, down from $42.5 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $42.5 million in Q1 2026, with the low at -$78.0 million in Q4 2024.
• Historically, Net Income towards Common Stockholders has averaged $526588.2 across 5 years, with a median of $7.4 million in 2024.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders surged 276.64% — and 2025, when it slumped 1523.57%.
• Staar Surgical's Net Income towards Common Stockholders stood at $29.9 million in 2022, then plunged by 63.11% to $11.0 million in 2023, then sank by 808.12% to -$78.0 million in 2024, then jumped by 111.38% to $8.9 million in 2025, then slumped by 41.4% to $5.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $5.2 million (Q2 2026), $42.5 million (Q1 2026), and $8.9 million (Q3 2025), per Business Quant data.